Loading quotes...
Forecast
There is no analyst data available for this company.
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Financials
| (EUR) | June 2025 | YoY |
|---|---|---|
| Revenue | 319.73K | - |
| Gross profit | 285.06K | - |
| Net profit | -1.68M | - |
| EBITDA | -1.67M | - |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €32.64M |
Number of shares | 75.5M |
52-week high/low | €0.65 - €0.0695 |
| Dividends | No |
Beta | -0.43 |
P/E ratio | -1.75 |
PEG ratio | 0.05 |
P/B ratio | 126.36 |
P/S ratio | 17.64 |
Company profile
Treatment.Com International Inc. provides personalized health care information services in Canada. It also develops a mobile application for symptom assessment of users to address their health concerns, problems, and ongoing wellness management. The company offers a digital health app, an assessment tool which provides insights about health. In addition, the company provides medical education, medical clinic, and clinical advisor solutions; and offers healthcare information resource. Treatment.Com International Inc. was incorporated in 2018 and is headquartered in Vancouver, Canada.
| Name | Treatment.com International Aktie |
| CEO | Essam Hamza |
| Headquarters | Vancouver,
bc Canada |
| Website | |
| IPO | 04/19/2021 |
| Employees | 3 |
Ticker symbols
| Exchange | Symbol |
|---|---|
Pnk | TREIF |
Cnq | TRUE.CN |
Frankfurt | 939.F |
MĂĽnchen | 939.MU |
DĂĽsseldorf | 939.DU |